Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera (Affiliated to the Technion Faculty of Medicine, Haifa, Israel).
Department of Internal Medicine, Hillel Yaffe Medical Center (Affiliated to the Technion Faculty of Medicine, Haifa, Israel).
Eur J Gastroenterol Hepatol. 2021 Jan;33(1):50-53. doi: 10.1097/MEG.0000000000001839.
The detection of obstructive colorectal cancer (CRC) masses during endoscopic examination hindering the passage of endoscope and precluding complete examination is not uncommon. The significance and implications of this finding on patients' prognosis and outcomes were not fully investigated and will be addressed in this study.
In this retrospective cohort study, we reviewed endoscopy, surgery, pathology and oncology reports of patients diagnosed with CRC over a 10-year period (2007-2016). We compared surgical stages, histologic grades and overall survival between patients with subclinical obstructive tumors at endoscopy to those with nonobstructive tumors. We performed multivariate analysis to identify independent risk factors associated with advanced CRC stage at diagnosis.
A total of 144 patients had obstructive colonic tumors while 254 had nonobstructive tumors and constituted the control group. Obstructive CRC group was significantly associated with advanced tumor stage at diagnosis (69 vs. 42%, OR = 3.018, 95% CI, 1.951-4.670; P < 0.01) and had prominently higher rates of moderate to poorly differentiated tumors (64.5 vs. 38.4%; P < 0.001) when compared to non-obstructive controls. Patients with obstructive tumors were significantly associated with decreased five years overall survival (53.4 vs. 67.3% vs.; P < 0.01). Increased overall mortality was observed in survival curves of patients with obstructive tumors along all follow-up periods.
Even in the absence of clinical sequela, obstructive CRC at endoscopic level may be associated with higher stage at diagnosis and reduced overall survival. Further prospective studies are warranted to confirm these findings and address their implication on patients' management.
在内镜检查中发现阻塞性结直肠癌(CRC)肿块,阻碍内镜通过并妨碍完成全面检查的情况并不少见。然而,这种发现对患者预后和结局的意义和影响尚未得到充分研究,本研究将对此进行探讨。
本回顾性队列研究分析了 10 年间(2007-2016 年)诊断为 CRC 的患者的内镜、手术、病理和肿瘤学报告。我们比较了内镜下有亚临床阻塞性肿瘤和无阻塞性肿瘤的患者的手术分期、组织学分级和总生存率。我们进行了多变量分析,以确定与诊断时晚期 CRC 相关的独立危险因素。
共有 144 例患者存在结肠阻塞性肿瘤,254 例患者存在非阻塞性肿瘤作为对照组。阻塞性 CRC 组在诊断时肿瘤分期明显更晚(69%比 42%,OR=3.018,95%CI 1.951-4.670;P<0.01),且中-低分化肿瘤的比例明显更高(64.5%比 38.4%;P<0.001)。与非阻塞性对照组相比,阻塞性肿瘤患者的五年总生存率明显降低(53.4%比 67.3%;P<0.01)。在所有随访期间,阻塞性肿瘤患者的生存曲线均显示出更高的总死亡率。
即使没有临床后遗症,内镜水平的阻塞性 CRC 也可能与更高的诊断分期和降低的总生存率相关。需要进一步的前瞻性研究来证实这些发现,并探讨其对患者管理的影响。